R. Hirschwehr et al., IDENTIFICATION OF COMMON ALLERGENIC STRUCTURES IN MUGWORT AND RAGWEEDPOLLEN, Journal of allergy and clinical immunology, 101(2), 1998, pp. 196-206
Background: Despite the rare occurrence of ragweed in Middle Europe, a
surprisingly high number of patients allergic to mugwort, a frequentl
y encountered weed, display IgE reactivity against ragweed pollen alle
rgens. Objective: The aim of this study was to investigate whether the
high prevalence of IgE reactivity against ragweed in patients allergi
c to mugwort is caused by the presence of common allergenic determinan
ts. We also sought to characterize any cross-reactive allergens. Metho
ds: Common allergenic structures in mugwort and ragweed pollen were ch
aracterized by qualitative IgE immunoblot inhibition experiments perfo
rmed with natural allergen extracts and recombinant allergens. The deg
ree of cross-reactivity was estimated by quantitative CAP-FEIA competi
tions. The clinical significance of cross-reactive IgE antibodies was
studied with histamine release experiments and nasal provocation tests
. Results: Mugwort and ragweed RAST values were significantly correlat
ed in a population of 82 Austrian patients allergic to mugwort. IgE an
tibodies cross-reacted with allergens of comparable molecular weight t
hat were present in both extracts: By using recombinant birch profilin
and specific antisera for IgE inhibition experiments, profilin was id
entified as one of the cross-reactive components in mugwort and ragwee
d pollen. Preincubation of sera from patients allergic to mugwort with
mugwort extract inhibited IgE binding to ragweed pollen extract great
er than 80%. Mugwort and ragweed pollen extract induced comparable his
tamine release and reduction of nasal air how in a patient with IgE re
activity against the major mugwort allergen Art v 1. Conclusion: In ad
dition to profilin, mugwort and ragweed pollen contain a number of cro
ss-reactive allergens, among them the major mugwort allergen Art v 1.
Cross-reactive IgE antibodies can lead to clinically significant aller
gic reactions.